SELLAS Life Sciences Group (SLS) Earnings Date, Estimates & Call Transcripts → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free SLS Stock Alerts $1.36 +0.06 (+4.63%) (As of 05/10/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryLatest Earnings DateMar. 28EstimatedActual EPS (Mar. 28) -$0.25 Missed By -$0.25 Get SELLAS Life Sciences Group Earnings AlertsEnter your email address below to receive the latest news and earnings results for SLS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueSLS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SLS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyObama’s Forever Term [exposed]America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here SELLAS Life Sciences Group Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.95) EPSSLS Earnings Date and InformationSELLAS Life Sciences Group last announced its quarterly earnings results on March 28th, 2024. The reported ($0.25) earnings per share for the quarter. SELLAS Life Sciences Group has generated ($1.36) earnings per share over the last year (($1.36) diluted earnings per share). Read More SELLAS Life Sciences Group Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript3/28/2024Q4 2023-($0.25)($0.25)($0.25)--11/9/2023Q3 2023-($0.33)($0.33)($0.33)--8/10/2023Q2 2023-($0.31)($0.31)($0.31)--5/11/2023Q1 2023-($0.47)($0.47)($0.47)--3/30/2023Q4 2022-($0.15)($0.15)($0.15)--3/16/2023Q4 2022-($0.43)($0.43)($0.43)--Elon Musk Secret Crypto Plot Exposed (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy.11/14/2022Q3 2022-($0.34)($0.34)($0.34)--11/8/2022Q3 2022-($0.12)($0.12)($0.12)--8/11/2022Q2 2022-($0.41)($0.41)($0.41)--8/9/2022Q2 2022-($0.18)($0.18)($0.18)--5/13/2022Q1 2022-($0.19)($0.19)($0.19)--5/12/2022Q1 2022-($1.05)($1.05)($1.05)-$1.00 million3/31/2022Q4 2021-($0.42)($0.42)($0.42)--11/12/2021Q3 2021($0.36)($0.45)($0.09)($0.45)--8/13/2021Q2 2021($0.13)($0.13)-($0.13)--8/12/2021Q2 2021($0.41)($0.30)+$0.11($0.30)-$1.90 million5/13/2021Q1 2021-($0.16)($0.16)($0.16)-$5.70 million5/13/2021Q1($0.27)($0.16)+$0.11($0.16)-$5.70 million SELLAS Life Sciences Group Earnings - Frequently Asked Questions When did SELLAS Life Sciences Group announce their last quarterly earnings? SELLAS Life Sciences Group (NASDAQ:SLS) last announced its quarterly earning data on Thursday, March 28, 2024. Learn more on SLS's earnings history. How much revenue does SELLAS Life Sciences Group generate each year? SELLAS Life Sciences Group (NASDAQ:SLS) has a recorded annual revenue of $1 million. How much profit does SELLAS Life Sciences Group generate each year? SELLAS Life Sciences Group (NASDAQ:SLS) has a recorded net income of -$37.34 million. SLS has generated -$1.36 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: LABP Earnings ASMB Earnings CARM Earnings YS Earnings RLYB Earnings DERM Earnings ANEB Earnings SCYX Earnings CRVS Earnings MNOV Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:SLS) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & CompanyRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SELLAS Life Sciences Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
